Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Dobbins

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2016
A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary CirrhosisP Zuo, R L Dobbins, R L O'Connor-Semmes, et al.
The American Journal of Physiology|March 1, 1994
Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dogR L Dobbins, S N Davis, D W Neal, et al.
Diabetes|January 9, 2001
Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in ratsR L Dobbins, L S Szczepaniak, B Bentley, et al.
Diabetes|September 30, 1998
Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humansR L Dobbins, M W Chester, M B Daniels, et al.
Metabolism: Clinical and Experimental|February 24, 1998
Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogsR L Dobbins, S N Davis, D Neal, et al.
Metabolism: Clinical and Experimental|April 1, 1995
Compartmental modeling of glucagon kinetics in the conscious dogR L Dobbins, S N Davis, D W Neal, et al.
The Journal of Clinical Investigation|June 17, 1998
A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretionR L Dobbins, M W Chester, B E Stevenson, et al.
The American Journal of Physiology|December 1, 1991
Role of glucagon in countering hypoglycemia induced by insulin infusion in dogsR L Dobbins, C C Connolly, D W Neal, et al.
Diabetes, Obesity & Metabolism|July 8, 2011
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patientsR L Dobbins, R O'Connor-Semmes, A Kapur, et al.
Diabetes Research and Clinical Practice|March 1, 1996
Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dogC C Connolly, R E Ivy, B A Adkins-Marshall, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|August 19, 2016
A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary CirrhosisP Zuo, R L Dobbins, R L O'Connor-Semmes, et al.
The American Journal of Physiology|March 1, 1994
Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dogR L Dobbins, S N Davis, D W Neal, et al.
Diabetes|January 9, 2001
Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in ratsR L Dobbins, L S Szczepaniak, B Bentley, et al.
Diabetes|September 30, 1998
Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humansR L Dobbins, M W Chester, M B Daniels, et al.
Metabolism: Clinical and Experimental|February 24, 1998
Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogsR L Dobbins, S N Davis, D Neal, et al.
Metabolism: Clinical and Experimental|April 1, 1995
Compartmental modeling of glucagon kinetics in the conscious dogR L Dobbins, S N Davis, D W Neal, et al.
The Journal of Clinical Investigation|June 17, 1998
A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretionR L Dobbins, M W Chester, B E Stevenson, et al.
The American Journal of Physiology|December 1, 1991
Role of glucagon in countering hypoglycemia induced by insulin infusion in dogsR L Dobbins, C C Connolly, D W Neal, et al.
Diabetes, Obesity & Metabolism|July 8, 2011
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patientsR L Dobbins, R O'Connor-Semmes, A Kapur, et al.
Diabetes Research and Clinical Practice|March 1, 1996
Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dogC C Connolly, R E Ivy, B A Adkins-Marshall, et al.
Pageof 2